Literature DB >> 26635425

Phobic Anxiety and Plasma Levels of Global Oxidative Stress in Women.

Kaitlin A Hagan1, Tianying Wu2, Eric B Rimm3, A Heather Eliassen1, Olivia I Okereke4.   

Abstract

BACKGROUND AND OBJECTIVES: Psychological distress has been hypothesized to be associated with adverse biologic states such as higher oxidative stress and inflammation. Yet, little is known about associations between a common form of distress - phobic anxiety - and global oxidative stress. Thus, we related phobic anxiety to plasma fluorescent oxidation products (FlOPs), a global oxidative stress marker.
METHODS: We conducted a cross-sectional analysis among 1,325 women (aged 43-70 years) from the Nurses' Health Study. Phobic anxiety was measured using the Crown-Crisp Index (CCI). Adjusted least-squares mean log-transformed FlOPs were calculated across phobic categories. Logistic regression models were used to calculate odds ratios (OR) comparing the highest CCI category (≥6 points) vs. lower scores, across FlOPs quartiles.
RESULTS: No association was found between phobic anxiety categories and mean FlOP levels in multivariable adjusted linear models. Similarly, in multivariable logistic regression models there were no associations between FlOPs quartiles and likelihood of being in the highest phobic category. Comparing women in the highest vs. lowest FlOPs quartiles: FlOP_360: OR=0.68 (95% CI: 0.40-1.15); FlOP_320: OR=0.99 (95% CI: 0.61-1.61); FlOP_400: OR=0.92 (95% CI: 0.52, 1.63).
CONCLUSIONS: No cross-sectional association was found between phobic anxiety and a plasma measure of global oxidative stress in this sample of middle-aged and older women.

Entities:  

Keywords:  Anxiety; Biochemical markers; Biological psychiatry; Oxidative Stress; Phobic Anxiety

Year:  2015        PMID: 26635425      PMCID: PMC4664194          DOI: 10.4321/S0213-61632015000100001

Source DB:  PubMed          Journal:  Eur J Psychiatry        ISSN: 0213-6163


  47 in total

1.  If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.

Authors:  Gregory E Miller; Edith Chen; Eric S Zhou
Journal:  Psychol Bull       Date:  2007-01       Impact factor: 17.737

2.  Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder.

Authors:  Serpil Ersan; Sevtap Bakir; E Erdal Ersan; Orhan Dogan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-05-08       Impact factor: 5.067

3.  Depression and possible cancer risk due to oxidative DNA damage.

Authors:  Masahiro Irie; Masakazu Miyata; Hiroshi Kasai
Journal:  J Psychiatr Res       Date:  2005-04-26       Impact factor: 4.791

4.  Impairment of several immune functions in anxious women.

Authors:  Lorena Arranz; Noelia Guayerbas; Mónica De la Fuente
Journal:  J Psychosom Res       Date:  2007-01       Impact factor: 3.006

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis.

Authors:  W E Copeland; L Shanahan; C Worthman; A Angold; E J Costello
Journal:  Psychol Med       Date:  2012-04-30       Impact factor: 7.723

7.  Discriminant validity of the Crown-Crisp Experiential Index.

Authors:  P M Burgess; L Mazzocco; I M Campbell
Journal:  Br J Med Psychol       Date:  1987-03

8.  Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies.

Authors:  Tianying Wu; Walter C Willett; Nader Rifai; Eric B Rimm
Journal:  Am J Epidemiol       Date:  2007-07-05       Impact factor: 4.897

9.  Stability of measurements of biomarkers of oxidative stress in blood over 36 hours.

Authors:  Tianying Wu; Nader Rifai; L Jackson Roberts; Walter C Willett; Eric B Rimm
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-08       Impact factor: 4.254

10.  Anxiety disorders and inflammation in a large adult cohort.

Authors:  N Vogelzangs; A T F Beekman; P de Jonge; B W J H Penninx
Journal:  Transl Psychiatry       Date:  2013-04-23       Impact factor: 6.222

View more
  1 in total

1.  Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses.

Authors:  Michael Maes; Kamila Landucci Bonifacio; Nayara Rampazzo Morelli; Heber Odebrecht Vargas; Estefânia Gastaldello Moreira; Drozdstoy St Stoyanov; Décio Sabbatini Barbosa; André F Carvalho; Sandra Odebrecht Vargas Nunes
Journal:  Neurotox Res       Date:  2018-05-07       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.